Active substance
Selenious acid
- US FDA 9
- Safety 1
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| SELENIOUS ACID | EQ 600MCG SELENIUM/10ML (EQ 60MCG SELENIUM/ML); EQ 60MCG SELENIUM/ML (EQ 60MCG SELENIUM/ML); EQ 12MCG SELENIUM/2ML (EQ 6MCG SELENIUM/ML) | solution · intravenous | AM REGENT | Prescription | 30 Apr 2019 |
| SELENIOUS ACID | EQ 600MCG SELENIUM/10ML (EQ 60MCG SELENIUM/ML) | solution · intravenous | SUN PHARM | Prescription | 20 Feb 2025 |
| SELENIOUS ACID | EQ 12MCG SELENIUM/2ML (EQ 6MCG SELENIUM/ML); EQ 600MCG SELENIUM/10ML (EQ 60MCG SELENIUM/ML) | solution · intravenous | ASPIRO | Prescription | 11 Jun 2025 |
| SELENIOUS ACID | EQ 600MCG SELENIUM/10ML (EQ 60MCG SELENIUM/ML) | solution · intravenous | GLAND | Prescription | 8 Jul 2025 |
| SELENIOUS ACID | EQ 60MCG SELENIUM/ML (EQ 60MCG SELENIUM/ML); EQ 600MCG SELENIUM/10ML (EQ 60MCG SELENIUM/ML) | solution · intravenous | STIRA | Prescription | 31 Dec 2025 |
| SELENIOUS ACID | EQ 600MCG SELENIUM/10ML (EQ 60MCG SELENIUM/ML) | solution · intravenous | EMERGE BIOSCIENCE | Prescription | 3 Feb 2026 |
| SELENIOUS ACID | EQ 12MCG SELENIUM/2ML (EQ 6MCG SELENIUM/ML); EQ 60MCG SELENIUM/ML (EQ 60MCG SELENIUM/ML); EQ 600MCG SELENIUM/10ML (EQ 60MCG SELENIUM/ML) | solution · intravenous | ZYDUS PHARMS | Prescription | 30 Jun 2026 |
| SELENIOUS ACID | EQ 600MCG SELENIUM/10ML (EQ 60MCG SELENIUM/ML) | solution · intravenous | FRESENIUS KABI USA | Discontinued | 10 Feb 2025 |
| SELENIOUS ACID | EQ 12MCG SELENIUM/2ML (EQ 6MCG SELENIUM/ML); EQ 600MCG SELENIUM/10ML (EQ 60MCG SELENIUM/ML) | solution · intravenous | CIPLA | Discontinued | 21 Jul 2025 |
Safety signals and safety-related labeling changes
- US FDA 30 Jun 2021 TRALEMENT — safety-related labeling change
Labeling sections changed: Warnings and Precautions; Use in Specific Populations
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.